Dr Jonathan Pritchard has secured a prestigious fellowship to support his research into the direct exploitation of quantum phenomena. His project aims to develop a hybrid device combining atoms and superconducting circuits for scalable quantum networking, with potential applications in computing, finance, and more.
A new UK Biobank study has identified six independent genetic variants associated with lung health and chronic obstructive pulmonary disease (COPD). The findings also suggest that genetic variations affecting gene regulation may play a role in COPD, providing potential targets for novel therapeutic strategies.
The AAO-HNS Foundation is developing a clinical data registry for otolaryngology, with Regent being the first registry of its kind. The registry will help improve patient care by tracking care outcomes and identifying gaps in clinician knowledge and performance.
A team of ETH Zurich researchers has created a biomimetic dental prosthesis that replicates the structure and properties of teeth and seashells. The material, produced using magnetically assisted slip casting, exhibits improved durability and complexity, with potential applications in dentistry and beyond.
Researchers identified distinct characteristics among non-smoking patients with NSCLC, such as lower chronic obstructive pulmonary disease and heart disease rates. Non-smokers also exhibited longer survival periods after diagnosis compared to smokers.
Research at the American Academy of Otolaryngology's annual meeting finds that tobacco smoke exposure correlates with severity of sinusitis symptoms. Additionally, studies show a link between tobacco smoke exposure and an increased risk of oropharyngeal cancers and eustachian tube disorders in children.
A large study found that aspirin use after a cancer diagnosis significantly increases overall survival rates for patients with gastrointestinal tumours. The researchers analysed data from nearly 14,000 patients and discovered a strong association between aspirin use and improved survival.
Researchers at Toyohashi University of Technology discovered that immersing a zinc-based buffer layer in ammonia water doubles the conversion efficiency of CIGS solar cells, improving their performance from 6.8% to 13.7%. The study reveals the importance of the buffer layer structure and composition for next-generation solar cells.
New study results show atezolizumab has remarkable activity in large number of patients with refractory lung cancer, regardless of treatment line. Efficacy is correlated with PD-L1 expression on tumours and immune cells.
The CheckMate 057 trial shows that nivolumab improves overall and 12-month survival rates compared to docetaxel in non-squamous non-small cell lung cancer patients. Nivolumab also demonstrated better patient-reported outcomes, including quality of life and slower disease deterioration.
Researchers found that infants infected with rhinovirus had lower respiratory microbiota diversity, while asymptomatic infections did not. Frequent early-life viral infections were also associated with reduced overall microbiota diversity.
Researchers found that adding hormonal treatment during chemotherapy reduced the risk of premature ovarian failure by 45% and increased pregnancy rates among young breast cancer patients. The use of LHRHa could be a potential standard strategy to preserve ovarian function and fertility in hormone receptor positive breast cancers.
A study by Mrs Lee Koh found that walking on side-street routes instead of main roads can reduce peaks in harmful air pollution. By avoiding busy streets, individuals can minimize their short-term and long-term exposure to black carbon particulate matter, a major component of urban air pollution.
A combination of dabrafenib and trametinib significantly prolongs median overall survival time for advanced melanoma patients to over two years, with 51% remaining alive after two years. The treatment also improves disease-free progression and quality of life compared to vemurafenib alone.
Researchers found that shielding parenteral nutrition from light significantly decreases oxidative stress and cell damage in premature infants, improving their survival rates. The study's findings suggest a potential solution for reducing mortality rates in preterm infants born between 26-31 weeks of gestation.
Shigeki Watanabe has developed a novel ultrafast technique called 'flash-and-freeze' to visualize nerve cell activity on a rapid time scale. The technique reveals that vesicle recycling in neurons occurs through two mechanisms, an ultrafast one and a slower clathrin-dependent process.
A two-drug combination of venlafaxine and aripiprazole relieved depression in 44% of treatment-resistant patients over 60, while reducing suicidal thoughts. The study's findings suggest that older adults may respond to this treatment strategy, offering new hope for those with hard-to-treat depression.
Researchers found that the combination therapy improved progression-free survival across various sub-groups, including those with poor prognostic factors. The study also showed similar efficacy regardless of BRAF mutation status and disease stage.